AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters

September 22, 2026 at 08:10 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

USA

Tags

obesity drug pharmaceuticals shares surge stock surge viking therapeutics weight loss

All Coverage

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPVkU1WW0wcFNxNy1FMHdKaGpieUFiLUliREc4M1gzTENwWl9VTDY1amJ3QTJYc2Y2MUxyTnE2aGhJWUJWd25vMEhaMURqbFY2dk9BWXo0WlRwMENsLWZZZ0tpYUJjTFlsYTlsNWk5R2xVbWtSbXctLTBVbk16ZGhVdWdGTWpwcUNLYUJxZGdwSzlCSXhEWGNnd09wQzVhZWZMYnVkN2xKY0l1cjdDTTEyY1R1Vk43Qmpnc1RYQVJLZmpEN3o3dTBaY0JKOA?oc=5" target="_blank">Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com

September 21, 2026 at 05:02 AM

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters

September 22, 2026 at 11:25 AM

Novo CEO says pills could capture 50% of weight-loss market by 2030 - Reuters

Novo CEO says pills could capture 50% of weight-loss market by 2030 Reuters

September 22, 2026 at 03:16 PM

Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology - Reuters

Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology Reuters

September 25, 2026 at 02:14 PM

Merck's drug for diabetes-related eye disease meets trial goal - Reuters

Merck's drug for diabetes-related eye disease meets trial goal Reuters

September 24, 2026 at 02:52 PM

Novo Nordisk open to direct New York listing, CEO Doustdar tells FT - Reuters

Novo Nordisk open to direct New York listing, CEO Doustdar tells FT Reuters

September 23, 2026 at 04:13 AM